DrugCite
Search

ALL OTHER NON THERAPEUTIC PRODUCTS

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

All Other Non Therapeutic Products Adverse Events Reported to the FDA Over Time

How are All Other Non Therapeutic Products adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for All Other Non Therapeutic Products, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if All Other Non Therapeutic Products is flagged as the suspect drug causing the adverse event.

Most Common All Other Non Therapeutic Products Adverse Events Reported to the FDA

What are the most common All Other Non Therapeutic Products adverse events reported to the FDA?

Depression
24 (1.71%)
Convulsion
21 (1.5%)
Anxiety
18 (1.29%)
Diarrhoea
16 (1.14%)
Dizziness
16 (1.14%)
Drug Withdrawal Syndrome Neonatal
15 (1.07%)
Food Interaction
15 (1.07%)
Nausea
15 (1.07%)
Drug Ineffective
14 (1%)
Cerebrovascular Accident
13 (.93%)
Drug Toxicity
13 (.93%)
Show More Show More
Dyspnoea
13 (.93%)
Hallucination
13 (.93%)
Loss Of Consciousness
12 (.86%)
Malaise
12 (.86%)
Pain
12 (.86%)
Asthenia
11 (.79%)
Cellulitis
11 (.79%)
Drug Interaction
11 (.79%)
Emphysema
11 (.79%)
Blood Cholesterol Increased
10 (.71%)
Blue Toe Syndrome
10 (.71%)
Completed Suicide
10 (.71%)
Dysarthria
10 (.71%)
Electrolyte Imbalance
10 (.71%)
Gait Disturbance
10 (.71%)
Limb Injury
10 (.71%)
Panic Attack
10 (.71%)
Surgery
10 (.71%)
Thinking Abnormal
10 (.71%)
Blister
9 (.64%)
Hypertension
9 (.64%)
Localised Infection
9 (.64%)
Poor Peripheral Circulation
9 (.64%)
Pulse Absent
9 (.64%)
Vomiting
9 (.64%)
Weight Increased
9 (.64%)
Condition Aggravated
8 (.57%)
Dehydration
8 (.57%)
Feeling Abnormal
8 (.57%)
Insomnia
8 (.57%)
Paraesthesia
8 (.57%)
Pruritus
8 (.57%)
Renal Failure
8 (.57%)
Tremor
8 (.57%)
Visual Acuity Reduced
8 (.57%)
Fall
7 (.5%)
Fatigue
7 (.5%)
Hyperhidrosis
7 (.5%)
Suicide Attempt
7 (.5%)
Unevaluable Event
7 (.5%)
Venous Insufficiency
7 (.5%)
Abdominal Pain Upper
6 (.43%)
Abnormal Behaviour
6 (.43%)
Amnesia
6 (.43%)
Crying
6 (.43%)
Death
6 (.43%)
Drug Hypersensitivity
6 (.43%)
Dyspepsia
6 (.43%)
Headache
6 (.43%)
Abasia
5 (.36%)
Agitation
5 (.36%)
Arthritis
5 (.36%)
Blood Creatinine Increased
5 (.36%)
Disturbance In Attention
5 (.36%)
Drug Exposure During Pregnancy
5 (.36%)
Drug Screen Positive
5 (.36%)
Heart Rate Increased
5 (.36%)
Hypersensitivity
5 (.36%)
Memory Impairment
5 (.36%)
Mental Disorder
5 (.36%)
Osteoarthritis
5 (.36%)
Palpitations
5 (.36%)
Suicidal Ideation
5 (.36%)
Treatment Noncompliance
5 (.36%)
Urticaria
5 (.36%)
Weight Decreased
5 (.36%)
Abdominal Pain
4 (.29%)
Application Site Erythema
4 (.29%)
Arthralgia
4 (.29%)
Atrial Fibrillation
4 (.29%)
Back Pain
4 (.29%)
Balance Disorder
4 (.29%)
Blood Pressure Decreased
4 (.29%)
Blood Pressure Increased
4 (.29%)
Cardiac Arrest
4 (.29%)
Cardiac Disorder
4 (.29%)
Chest Pain
4 (.29%)
Coma
4 (.29%)
Drug Dependence
4 (.29%)
Drug Effect Decreased
4 (.29%)
Dry Eye
4 (.29%)
Eye Disorder
4 (.29%)
Gastrointestinal Haemorrhage
4 (.29%)
Hot Flush
4 (.29%)
Liver Disorder
4 (.29%)
Nerve Injury
4 (.29%)
Oedema Peripheral
4 (.29%)
Pain In Extremity
4 (.29%)
Poisoning Deliberate
4 (.29%)
Rash
4 (.29%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for All Other Non Therapeutic Products, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if All Other Non Therapeutic Products is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for All Other Non Therapeutic Products

What are the most common All Other Non Therapeutic Products adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for All Other Non Therapeutic Products, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if All Other Non Therapeutic Products is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of All Other Non Therapeutic Products According to Those Reporting Adverse Events

Why are people taking All Other Non Therapeutic Products, according to those reporting adverse events to the FDA?

Ill-defined Disorder
101
Drug Use For Unknown Indication
23
Psoriasis
11
Suicide Attempt
9
Product Used For Unknown Indication
6
Withdrawal Syndrome
3
Show More Show More
Aphrodisiac Therapy
2
Back Pain
2
Dyslipidaemia
2
Vulval Cancer
2
Postoperative Adhesion
2
Tinea Pedis
2
Anxiety
2
Rectal Cancer
2
Catheterisation Cardiac
1
Self Injurious Behaviour
1
Drug Abuse
1
Accidental Exposure
1
Bladder Disorder
1
Occupational Exposure To Toxic Agen...
1
Sciatica
1
Pain
1
Surgery
1
Erectile Dysfunction
1
Skin Laceration
1
Denture Wearer
1
Asthenia
1
Colonoscopy
1
Constipation
1
Nasopharyngitis
1
Inadequate Diet
1
Tenderness
1
Non-small Cell Lung Cancer
1
Skin Disorder
1
Dermatitis Contact
1

All Other Non Therapeutic Products Case Reports

What All Other Non Therapeutic Products safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for All Other Non Therapeutic Products. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with All Other Non Therapeutic Products.